Home › Rectal Cancer › Indiana › Indianapolis
Rectal Cancer clinical trials in Indianapolis, IN
3 studies for Rectal Cancer are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
RecruitingPhase 3
- Franciscan Health ( Site 2025), Indianapolis
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RecruitingHealthy volunteers welcome
- Saint Catherine Hospital, Indianapolis
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- Community Health Network, Indianapolis
Rectal Cancer trials in other cities
- New York City, NY17 studies
- Boston, MA12 studies
- Houston, TX11 studies
- Los Angeles, CA10 studies
- St. Louis, MO10 studies
- Chicago, IL10 studies
- Columbus, OH9 studies
- Seattle, WA9 studies
- Tampa, FL9 studies
- Aurora, CO8 studies
- Nashville, TN8 studies
- Philadelphia, PA8 studies
Other studies in Indianapolis
- Non-Small Cell Lung Cancer32 studies
- Cancer (all types)24 studies
- Heart Failure24 studies
- Obesity22 studies
- Breast Cancer19 studies
- Ovarian Cancer18 studies
- Metastatic Cancer17 studies
- Colorectal Cancer17 studies
- Cardiovascular Disease16 studies
- Lung Cancer16 studies
- Type 1 Diabetes14 studies
- Overweight14 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.